Peter Amos, Ph.D.

Peter’s patent practice focuses on developing client-first patent strategies for businesses and institutions of all sizes and stages, leveraging his extensive track record of building and maintaining effective patent portfolios and his experience with defending and asserting clients’ patent rights.
Peter’s patent practice has included substantial work on innovations in biomedical devices such as computer-assisted and AI-based image analysis, surgical instruments, surgical implants, networked systems, flow cytometry, and bioreactors; biotechnology, including antibodies, advanced sequencing technologies, CAR-T platforms, and genetic engineering platforms such as CRISPR; and mechanical engineering, including slew drives and air ventilation systems. Peter has also successfully prosecuted innovations in virtual reality gaming.
Peter has led prosecution of patent portfolios of all sizes, from drafting and prosecuting initial patent applications for early-stage start-ups and single inventors to developing and optimizing portfolios of dozens of patent families supporting multinational corporations. Peter has extensive experience with patent strategy, seamlessly extending from business-focused patent portfolio creation, timing, and maintenance to freedom-to-operate analysis, patentability analysis, and client-side and investor-side due diligence. In addition to patent prosecution and portfolio strategy, Peter also has significant experience with post-grant proceedings in front of the US Patent & Trademark Office as well as at the Federal Circuit level.
Prior to joining Lee & Hayes, Peter spent 10 years as a patent agent at Vault Law 100/Am Law 100 law firms. Peter’s bachelor’s degree and Ph.D. were earned in biomedical engineering with focuses on biomedical devices, mechanical engineering, and tissue engineering, and he has completed postdoctoral fellowships at Yale University School of Medicine’s Cardiovascular Research Center, University of Washington’s Neurology Department, and the US Veteran’s Affairs Puget Sound Health Care System’s research affiliate. His academic training and research provides a deep understanding of biomedical instrumentation and bioengineering systems, cardiovascular engineering, biomechanics, stem cell engineering, molecular biology, and neurobiology. Peter also draws on his experience in contract analytical chemistry using LC-MS-MS systems to analyze clinical and pre-clinical patient samples.